Management of Severe Hyperglycemia

Initial Treatment Approach

For patients with HbA1c levels ≥10-12%, the American College of Physicians recommends basal insulin plus mealtime insulin as the preferred initial regimen, with initial dosing of basal insulin started at 10 units or 0.1-0.2 units/kg of body weight 1, 2
The American Diabetes Association suggests that insulin should be used without delay when severe hyperglycemia is present, as timely intervention is crucial for preventing complications 2, 3
Metformin should be continued or initiated alongside insulin therapy unless contraindicated, as it improves insulin sensitivity and may reduce insulin requirements, according to the American College of Physicians 4

A comprehensive insulin regimen should include basal insulin for background glucose control and rapid-acting insulin before meals to control postprandial glucose excursions, as recommended by the American Association of Clinical Endocrinologists 2, 3
Insulin dose titration should be based on self-monitoring of blood glucose results, with adjustments made every 2-3 days until target glucose values are achieved, according to the European Association for the Study of Diabetes 5
For patients with HbA1c >12%, more aggressive insulin titration may be necessary, with close monitoring for hypoglycemia, as suggested by the International Diabetes Federation 6

Regular self-monitoring of blood glucose should be performed, including fasting and postprandial measurements, to guide insulin dose adjustments, as recommended by the American Diabetes Association 5
Basal insulin doses should be adjusted based on fasting glucose readings, while mealtime insulin should be adjusted based on postprandial readings, according to the American College of Physicians 3
HbA1c should be rechecked after 3 months to assess the effectiveness of the treatment regimen, as suggested by the European Association for the Study of Diabetes 7

Once acute hyperglycemia is controlled, it may be possible to reduce or modify the insulin regimen, particularly if the patient shows good response to lifestyle modifications and oral agents, according to the American College of Physicians 8
For patients with renal impairment, insulin doses may need to be reduced due to decreased insulin clearance and impaired renal gluconeogenesis, as recommended by the National Kidney Foundation 9
Patients should be educated about insulin administration techniques, self-monitoring of blood glucose, hypoglycemia recognition and management, and sick day rules, as suggested by the American Diabetes Association 8

Delaying insulin therapy in patients with severely elevated HbA1c can lead to prolonged hyperglycemia and increased risk of complications, according to the American College of Physicians 1, 3
Inadequate insulin dosing or insufficient titration can result in persistent hyperglycemia, as suggested by the European Association for the Study of Diabetes 5
Discontinuing oral agents like metformin when starting insulin may reduce overall treatment effectiveness, according to the American College of Physicians 4
Failing to provide adequate patient education on insulin use and hypoglycemia management can lead to treatment failure or adverse events, as recommended by the American Diabetes Association 8